Navigation Links
Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinson's Disease
Date:11/14/2007

son's Disease

Parkinson's disease is a progressive movement disorder that affects at least one million people in the United States. It is caused by a reduction in dopamine containing nerve cells of the midbrain. Dopamine is a neurotransmitter involved in controlling movement and coordination, so Parkinson's patients experiencing a reduction of dopamine-producing nerve cells exhibit the progressive inability to initiate and control physical movements. There is currently no cure for Parkinson's disease.

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of nervous system growth factors for the treatment of neurodegenerative disorders using gene delivery. Ceregene's clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor that is currently in Phase 1/2 studies for the treatment of Alzheimer's disease, and CERE-120 (AAV2-Neurturin) which recently completed enrollment of a controlled Phase 2 study for Parkinson's disease. CERE-130 and CERE-140 are in preclinical development for ALS (Lou Gehrig's disease) and ocular disorders, respectively. Ceregene was launched in January 2001 and is a former subsidiary of Cell Genesys, Inc. (Nasdaq: CEGE). The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys as well as Hamilton BioVentures and California Technology Partners.


'/>"/>
SOURCE Ceregene, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Innerspire, LLC ( http://www.innerspire.com ) ... as a Creative Enrollment Specialist. In this role, Greg ... as well as his accomplished design skills to further ... and to service the creative marketing needs ... work with small business owners and individuals looking to ...
(Date:7/25/2014)... 25, 2014 The American Brain Tumor ... Talent Development Trainer of Distinguished Events, and Corporate and ... American Cancer Society, will be joining the ABTA in ... Ward will oversee the roll out of a nationwide ... , The recently launched volunteer network will provide the ...
(Date:7/25/2014)... The American Brain Tumor Association (ABTA) today unveiled branding ... annual patient and family conference in Chicago. , “This ... as we – the first and now only national ... brain tumor research – extend our reach by engaging ... getting our materials and services into the hands of ...
(Date:7/25/2014)... “You have a brain tumor.” These five words ... loved ones across the U.S. every day. According to the ... typically met with confusion and uncertainty as families struggle to ... make critical decisions about a course of treatment. The shock ... a sense of isolation and a frantic and, far too ...
(Date:7/25/2014)... Chicago, IL (PRWEB) July 25, 2014 There ... tumor, and 500 diagnosed each day. Though when someone hears ... alone, confused and are unsure of the next step and ... is helping people figure out that next step by providing ... knows this more than Brian Olson, member of the ABTA’s ...
Breaking Medicine News(10 mins):Health News:Innerspire, LLC Continues National Expansion 2Health News:Innerspire, LLC Continues National Expansion 3Health News:Innerspire, LLC Continues National Expansion 4Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:American Brain Tumor Association to Expand Service Reach with Launch of Nationwide Volunteer Network 2Health News:American Brain Tumor Association to Expand Service Reach with Launch of Nationwide Volunteer Network 3Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 2Health News:American Brain Tumor Association Board of Directors Member Shares Story of Brain Tumor Survivorship 3
... , WEDNESDAY, Sept. 14 (HealthDay News) -- ... new research suggests that people who kick the habit ... from the University of Missouri found that smoking is ... (often being emotionally negative and anxious) among adults under ...
... Alexandria, Va., USA - The International and American ... proceedings from the 3rd AADR Fall Focused Symposium ... symposium was held November 12-13, 2010, in Washington, ... Symposium under the objective to provide networking opportunities ...
... Division of Pain Medicine in the Department of ... Neurological Institute have each received 2011 Medical & ... Institutions for these nationally competitive awards are reviewed ... comprised of leaders in the field. The ...
... likely than Caucasians to be not only diagnosed with head and ... answer isn,t a simple one, differences in lifestyle, access to care ... a new study from Henry Ford Hospital. The study also ... current smokers, one of the primary risk factors for head and ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- For ... on staff, "telestroke" may be a cost-effective option to ... say. Telestroke, or virtual stroke care, ... through two-way audio-video equipment. "In an era of ...
... The human papillomavirus (HPV) is more likely to be ... and those with private health insurance, according to a new ... also reveals that laryngeal cancer patients with Medicare, who tend ... HPV, suggesting that HPV infection may be closely tied to ...
Cached Medicine News:Health News:Quitting Smoking May Improve Personality, Study Suggests 2Health News:IADR/AADR publish proceedings from the AADR Fall Focused Symposium on Salivary Diagnostics 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 3Health News:Rural Stroke Victims May Benefit From 'Virtual' Care 2Health News:Gender, insurance type tied to HPV infection in laryngeal cancer patients 2Health News:Gender, insurance type tied to HPV infection in laryngeal cancer patients 3
(Date:7/25/2014)... WASHINGTON , July 25, 2014 Cardinal ... innovative community pharmacies as winners of its prestigious Independent ... Business Conference , one of the nation,s largest gatherings ... Competition winners – family-owned pharmacies from Ohio ... Texas – were selected for implementing ...
(Date:7/25/2014)... MARLTON, N.J. , July 25, 2014 /PRNewswire/ ... visibility, brand protection and serialization solutions, has recently ... Business" that addresses current and future needs ... solutions for the old supply chain model no ... advances in technology, including the growth of mobile ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc (OTC: ... the majority interest in Buzznbrewz.com and the Letter of ... with a fully executed Purchase Agreement. ... "We are proud to have Mr. David Pecoraro ... of experience in the private sector and developed a ...
Breaking Medicine Technology:Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Acsis Addresses Questions on the Modern Supply Chain 2Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2
... YORK, Dec. 7, 2011 Reportlinker.com announces ... available in its catalogue: ... Japan http://www.reportlinker.com/p0702529/Future-Therapeutic-Drug-Monitoring-Market-US-Europe-Japan.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... TDM market will undergo significant transformation. These ...
... Talyst announces AutoPharm® Mobile, an Apple iOS application ... can be conveniently accessed on an Apple iOS ... across the health system. AutoPharm ... access to medication inventory throughout the health system. ...
Cached Medicine Technology:Future Therapeutic Drug Monitoring Market: US, Europe, Japan 2Future Therapeutic Drug Monitoring Market: US, Europe, Japan 3Future Therapeutic Drug Monitoring Market: US, Europe, Japan 4Future Therapeutic Drug Monitoring Market: US, Europe, Japan 5Future Therapeutic Drug Monitoring Market: US, Europe, Japan 6Future Therapeutic Drug Monitoring Market: US, Europe, Japan 7Future Therapeutic Drug Monitoring Market: US, Europe, Japan 8Future Therapeutic Drug Monitoring Market: US, Europe, Japan 9Talyst Releases AutoPharm Mobile 2
Dust covers for a variety of Zeiss microscopes...
Inquire...
... An economical laboratory tissue culture microscope, ... to expand their applications. Olympus has taken ... the CKX41. Fluorescence can be used with ... images can be carried out on the ...
... Designed for the scientist who wants ... the TE2000E2 is a high precision Z-focus ... This makes it possible to expand ... sources and image outputs. A five-way ...
Medicine Products: